Sartorius Aktiengesellschaft (ETR:SRT3)

Market Cap	12.08B
Revenue (ttm)	3.38B
Net Income (ttm)	84.00M
Shares Out	69.04M
EPS (ttm)	1.22
PE Ratio	156.22
Forward PE	58.12
Dividend	0.74 (0.39%)
Ex-Dividend Date	Mar 28, 2025

Volume	175,962
Average Volume	145,533
Open	191.35
Previous Close	190.25
Day's Range	190.25 - 194.55
52-Week Range	166.05 - 341.50
Beta	1.33
RSI	39.83
Earnings Date	Apr 16, 2025

About ETR:SRT3

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cy...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1870
• Employees: 13,528
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: SRT3

Financial Performance

In 2024, ETR:SRT3's revenue was 3.38 billion, a decrease of -0.44% compared to the previous year's 3.40 billion. Earnings were 84.00 million, a decrease of -59.14%.